Vision Impairment News and Research RSS Feed - Vision Impairment News and Research

New study shows Ebola survivors may be at risk of severe vision loss

New study shows Ebola survivors may be at risk of severe vision loss

A new study has shown that Ebola survivors may be at risk of severe vision loss or blindness weeks after being declared virus-free. The research is being presented at the 2016 Annual Meeting of the Association for Research in Vision and Ophthalmology this week in Seattle, Wash. [More]
Diabetic patients at risk for developing retinal diabetic neuropathy

Diabetic patients at risk for developing retinal diabetic neuropathy

A University of Iowa-led study of diabetes-related vision impairment holds good news -- and some bad news -- for patients with signs of these disorders. [More]
Researchers discover gene that plays vital role in inherited eye disorder

Researchers discover gene that plays vital role in inherited eye disorder

Researchers from the University of Liverpool have identified a specific gene that plays a key role in an inherited eye disorder. [More]
ADHD highly prevalent among children with vision problems

ADHD highly prevalent among children with vision problems

Children with vision problems not correctable with glasses or contact lenses may be twice as likely to have a diagnosis of attention deficit/hyperactivity disorder (ADHD), suggests a study in the May issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer. [More]
New study to explore outcomes of pregnancy in Brazilian women with Zika virus

New study to explore outcomes of pregnancy in Brazilian women with Zika virus

An observational study of pregnant women in Brazil to further understand Zika virus and its impact on reproductive health and fetus development have been launched. William Britt, M.D., professor of pediatric infectious diseases at the University of Alabama at Birmingham, leads the study, which complements his current research in Brazil on cytomegalovirus infection during pregnancy. [More]
Uncorrected refractive error responsible for vision impairment in 101 million people worldwide

Uncorrected refractive error responsible for vision impairment in 101 million people worldwide

Uncorrected refractive error (URE)--nearsightedness, farsightedness, and other focusing problems correctable by prescription lenses--is responsible for moderate to severe vision impairment in 101 million people and blindness in seven million people worldwide, reports a study in the March issue of Optometry and Vision Science, official journal of the American Academy of Optometry. [More]
Homeless adults have more geriatric conditions than those living in homes

Homeless adults have more geriatric conditions than those living in homes

Homeless people in their fifties have more geriatric conditions than those living in homes who are decades older, according to researchers at UC San Francisco who are following 350 people who are homeless and aged 50 and over, in Oakland. [More]
New UAB study shows connection between ADHD and vision problems in children

New UAB study shows connection between ADHD and vision problems in children

Attention deficit/hyperactivity disorder is one of the most frequently encountered neurodevelopmental disorders of childhood, and a new study from researchers at the University of Alabama at Birmingham recently published in Optometry and Vision Science shows a relationship between ADHD and vision impairments in children. [More]
Study finds that half the world's population to be short-sighted by 2050

Study finds that half the world's population to be short-sighted by 2050

Half the world's population (nearly 5 billion) will be short-sighted (myopic) by 2050, with up to one-fifth of them (1 billion) at a significantly increased risk of blindness if current trends continue, says a study published in the journal Ophthalmology. [More]
New studies provide insights into impact of vision loss among survivors of childhood cancers

New studies provide insights into impact of vision loss among survivors of childhood cancers

Little is known about the long-term health of survivors of childhood cancers that affect vision, but two new studies provide valuable insights that could impact patient care and follow-up. The findings are published early online in CANCER, a peer-reviewed journal of the American Cancer Society. [More]

Up to 1 billion people could be at risk of going blind by 2050, say researchers

Up to 1 billion people could be at risk of blindness by the middle of the century if an emerging short-sightedness (myopia) epidemic is ignored say researchers at the Brien Holden Vision Institute. [More]
Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

Allergan receives FDA approval to market JUVEDERM ULTRA XC for use in lips

Allergan plc, a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration to market JUVEDERM ULTRA XC for injection into the lips and perioral area for lip augmentation in adults over the age of 21. JUVEDERM ULTRA XC instantly adds fullness to the lips and is the only dermal filler that has proven results lasting up to one year for lip augmentation. [More]
ILUVIEN continues to show positive results in Europe

ILUVIEN continues to show positive results in Europe

Alimera Sciences Limited, the European subsidiary of Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced the availability of real world data from 28 injections of ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) in Europe, presented in a review paper authored by Fahd Quhill, Consultant Ophthalmologist, Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield, South Yorkshire, U.K. [More]
Alimera Sciences announces results from ongoing study on ILUVIEN

Alimera Sciences announces results from ongoing study on ILUVIEN

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy. [More]

Brunel University student produces animated short film on understanding visually impaired people

As almost any of the UK's two million visually impaired (VI) will tell you people with full sight often make incorrect assumptions about their capabilities. [More]
Bayer Yakuhin receives MHLW approval in Japan for EYLEA (aflibercept) Injection to treat RVO patients

Bayer Yakuhin receives MHLW approval in Japan for EYLEA (aflibercept) Injection to treat RVO patients

Regeneron Pharmaceuticals, Inc. today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd., received approval for EYLEA (aflibercept) Injection by the Ministry of Health, Labour and Welfare (MHLW) in Japan for the treatment of patients with macular edema secondary to retinal vein occlusion (RVO). [More]
Envision presents awards for work in low vision rehabilitation

Envision presents awards for work in low vision rehabilitation

Envision presents the Lifetime Achievement Award from time-to-time to researchers whose careers have been marked by outstanding, creative and important contributions to low vision research... [More]
Johns Hopkins Ophthalmology professor Bob Massof receives Helen Keller prize

Johns Hopkins Ophthalmology professor Bob Massof receives Helen Keller prize

Bob Massof, Ph.D., of the Wilmer Eye Institute at Johns Hopkins received the 2015 Helen Keller Prize for Vision Research on May 5... [More]
Supporting people with macular degeneration: an interview with Dennis Lewis, AMD Alliance International

Supporting people with macular degeneration: an interview with Dennis Lewis, AMD Alliance International

Once depression sets in, it's very hard to combat. Combinations of medication and talking therapy can help deal with that, but it can be tough when people reach rock bottom and that certainly does happen with macular degeneration... [More]
TSRI study provides new insight into preventing diseases that cause vision loss in adults

TSRI study provides new insight into preventing diseases that cause vision loss in adults

A new study from scientists at The Scripps Research Institute shows that nerve cells and blood vessels in the eye constantly "talk" to each other to maintain healthy blood flow and prevent disease. [More]
Advertisement
Advertisement